Literature DB >> 23175699

Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.

Soma Rohatgi1, Liise-anne Pirofski.   

Abstract

The role of B cells in host defense against fungi has been difficult to establish. We quantified and determined the molecular derivation of B-1a, B-1b, and B-2 B cell populations in C57BL/6 mice after pulmonary infection with Cryptococcus neoformans. Total B-1 and B-2 cell numbers increased in lungs and peritoneal cavity as early as day 1 postinfection, but lacked signs of clonal expansion. Labeled capsular (24067) and acapsular (Cap67) C. neoformans strains were used to identify C. neoformans-binding B cell subsets by flow cytometry. Peritoneal cavity B-1a B cells exhibited the most acapsular and capsular C. neoformans binding in C. neoformans-infected mice, and C. neoformans-selected B-1 B cells secreted laminarin- and C. neoformans-binding IgM. Single-cell PCR-based sequence analysis of B-1a, B-1b, and B-2 cell IgH V region H chain (V(H)) genes revealed increased usage of V(H)11 and V(H)12, respectively, in acapsular and capsular C. neoformans-selected B-1a cells. Germline V(H) segments were used, with capsular C. neoformans-selected cells having less junctional diversity than acapsular C. neoformans-selected cells. Further studies in B-1 B cell-depleted mice showed that these mice had higher brain and lung fungal burdens and less alveolar macrophage phagocytosis of C. neoformans than did control and B-1a B cell-reconstituted mice. Taken together, these results establish a mechanistic role for B-1 B cells in the innate B cell response to pulmonary infection with C. neoformans and reveal that IgM-producing B-1a cells, which express germline V(H) genes, bind C. neoformans and contribute to early fungal clearance. Thus, B-1a B cells provide a first line of defense during pulmonary C. neoformans infection in mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175699      PMCID: PMC3518565          DOI: 10.4049/jimmunol.1201514

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  92 in total

1.  Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule.

Authors:  Amy J Reese; Tamara L Doering
Journal:  Mol Microbiol       Date:  2003-11       Impact factor: 3.501

2.  The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan.

Authors:  Antonio Nakouzi; Arturo Casadevall
Journal:  Mol Immunol       Date:  2003-10       Impact factor: 4.407

Review 3.  Peripheral development of B cells in mouse and man.

Authors:  Rita Carsetti; M Manuela Rosado; Hedda Wardmann
Journal:  Immunol Rev       Date:  2004-02       Impact factor: 12.988

4.  The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes.

Authors:  Kishore R Alugupalli; Rachel M Gerstein; Jianzhu Chen; Eva Szomolanyi-Tsuda; Robert T Woodland; John M Leong
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

5.  Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Authors:  Robert W Maitta; Kausik Datta; Andrew Lees; Shelley Sims Belouski; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  B1b lymphocytes confer T cell-independent long-lasting immunity.

Authors:  Kishore R Alugupalli; John M Leong; Robert T Woodland; Masamichi Muramatsu; Tasuku Honjo; Rachel M Gerstein
Journal:  Immunity       Date:  2004-09       Impact factor: 31.745

7.  Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Authors:  Robert W Maitta; Kausik Datta; Qing Chang; Robin X Luo; Bradley Witover; Krishanthi Subramaniam; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.

Authors:  N Nabavi; J W Murphy
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

9.  Experimental cryptococcosis in normal and B-cell-deficient mice.

Authors:  D P Monga; R Kumar; L N Mohapatra; A N Malaviya
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

10.  Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice.

Authors:  G Marquis; S Montplaisir; M Pelletier; S Mousseau; P Auger
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more
  22 in total

1.  Antibody immunity and natural resistance to cryptococcosis.

Authors:  N Trevijano-Contador; L Pirofski
Journal:  Curr Trop Med Rep       Date:  2019-04-04

2.  Human IgM Inhibits the Formation of Titan-Like Cells in Cryptococcus neoformans.

Authors:  Nuria Trevijano-Contador; Kaila M Pianalto; Connie B Nichols; Oscar Zaragoza; J Andrew Alspaugh; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

3.  Vaccination with Secreted Aspartyl Proteinase 2 Protein from Candida parapsilosis Can Enhance Survival of Mice during C. tropicalis-Mediated Systemic Candidiasis.

Authors:  Manisha Shukla; Soma Rohatgi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

Review 4.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 5.  Host immunity to Cryptococcus neoformans.

Authors:  Soma Rohatgi; Liise-Anne Pirofski
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 6.  Striking a balance: fungal commensalism versus pathogenesis.

Authors:  Iliyan D Iliev; David M Underhill
Journal:  Curr Opin Microbiol       Date:  2013-06-04       Impact factor: 7.934

7.  Early or late IL-10 blockade enhances Th1 and Th17 effector responses and promotes fungal clearance in mice with cryptococcal lung infection.

Authors:  Benjamin J Murdock; Seagal Teitz-Tennenbaum; Gwo-Hsiao Chen; Anthony J Dils; Antoni N Malachowski; Jeffrey L Curtis; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2014-09-15       Impact factor: 5.422

8.  X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.

Authors:  Wendy A Szymczak; Michael J Davis; Steven K Lundy; Chad Dufaud; Michal Olszewski; Liise-anne Pirofski
Journal:  MBio       Date:  2013-07-02       Impact factor: 7.867

9.  Commentary: Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development.

Authors:  Luis R Martinez
Journal:  Front Microbiol       Date:  2015-10-09       Impact factor: 5.640

10.  Fc gamma receptor 3A polymorphism and risk for HIV-associated cryptococcal disease.

Authors:  Soma Rohatgi; Shruti Gohil; Mark H Kuniholm; Hannah Schultz; Chad Dufaud; Kathryn L Armour; Sheila Badri; Robbie B Mailliard; Liise-anne Pirofski
Journal:  MBio       Date:  2013-08-27       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.